Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
194 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
45 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

A multi-objective constrained POMDP model for breast cancer screening (2206.05370v2)

Published 10 Jun 2022 in cs.AI

Abstract: Breast cancer is a common and deadly disease, but it is often curable when diagnosed early. While most countries have large-scale screening programs, there is no consensus on a single globally accepted guideline for breast cancer screening. The complex nature of the disease; the limited availability of screening methods such as mammography, magnetic resonance imaging (MRI), and ultrasound; and public health policies all factor into the development of screening policies. Resource availability concerns necessitate the design of policies which conform to a budget, a problem which can be modelled as a constrained partially observable Markov decision process (CPOMDP). In this study, we propose a multi-objective CPOMDP model for breast cancer screening which allows for supplemental screening methods to accompany mammography. The model has two objectives: maximize the quality-adjusted life years (QALYs) and minimize lifetime breast cancer mortality risk (LBCMR). We identify the Pareto frontier of optimal solutions for average and high-risk patients at different budget levels, which can be used by decision-makers to set policies in practice. We find that the policies obtained by using a weighted objective are able to generate well-balanced QALYs and LBCMR values. In contrast, the single-objective models generally sacrifice a substantial amount in terms of QALYs/LBCMR for a minimal gain in LBCMR/QALYs. Additionally, our results show that, with the baseline cost values for supplemental screenings as well as the additional disutility that they incur, they are rarely recommended in CPOMDP policies, especially in a budget-constrained setting. A sensitivity analysis reveals the thresholds on cost and disutility values at which supplemental screenings become advantageous to prescribe.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (13)
  1. ACS (2019) Breast cancer early detection and diagnosis. https://www.cancer.org/content/dam/CRC/PDF/Public/8579.00.pdf
  2. Arias E (2014) United states life tables, 2010. National Vital Statistics System 63(7):1–63
  3. Ayer T (2015) Inverse optimization for assessing emerging technologies in breast cancer screening. Annals of Operations Research 230(1):57–85
  4. Ebadi M, Akhavan-Tabatabaei R (2021) Personalized cotesting policies for cervical cancer screening: A pomdp approach. Mathematics 9(6):679
  5. Hajjar A, Alagoz O (2022) Personalized disease screening decisions considering a chronic condition. Management Science URL https://doi.org/10.1287/mnsc.2022.4336
  6. Kavaklioglu C, Cevik M (2022) Scalable grid-based approximation algorithms for partially observable markov decision processes. Concurrency and Computation: Practice and Experience 34(5):e6743
  7. Le QA (2016) Structural uncertainty of markov models for advanced breast cancer: a simulation study of lapatinib. Medical Decision Making 36(5):629–640
  8. Lovejoy WS (1991) Computationally feasible bounds for partially observed markov decision processes. Operations Research 39(1):162–175
  9. Mavrotas G (2009) Effective implementation of the ε𝜀\varepsilonitalic_ε-constraint method in multi-objective mathematical programming problems. Applied mathematics and computation 213(2):455–465
  10. Petousis P (2019) Optimizing cancer screening with pomdps. PhD thesis, UCLA
  11. Puterman ML (2014) Markov decision processes: discrete stochastic dynamic programming. John Wiley & Sons
  12. Sandikçi B (2010) Reduction of a pomdp to an mdp. Wiley Encyclopedia of Operations Research and Management Science
  13. Waks AG, Winer EP (2019) Breast cancer treatment: A review. Jama 321(3):288–300

Summary

We haven't generated a summary for this paper yet.